vomiting and seizures. He had previous history of epilepsy before three years. Seizures were managed with carbamazepine without definitive diagnosis. There had been increased frequency of medically refractory seizures since 12 months. Neurological examination was unremarkable. Routine laboratory investigations were within normal limits. On magnetic resonance (MR) imaging, left temporal lobe revealed multinodular mass. It was hypointense on T1 and hyperintense on T2-weighted images without surrounding vasogenic edema. Post-contrast scans revealed only small focal enhancement. Little mass effect was seen [ Figure 1 ]. Radiological diagnosis of DNET or low grade astrocytoma was made.
Introduction
Dysembryoplastic neuroepithelial tumour (DNET) is a rare mixed glioneuronal tumour. [1] [2] [3] [4] In 1993, World Health Organization (WHO) classified the DNET as a Grade I tumour. [2, 4] Only two cases of pilocytic astrocytoma (PA) with DNETs are reported. [1, 2] To the best of our knowledge, this is the third reported case of coexistent DNET with PA. DNET have the potential for recurrence and malignant transformation. [1, 2, [5] [6] [7] [8] [9] [10] The identification of DNET by surgical pathologist has therapeutic and prognostic implications because surgical outcome and prognosis is much better and aggressive chemo-radiotherapy can be avoided. [2, 4, 8, 11, 12] Here, we discuss a case of DNET with PA. We conclude that patients with unresected long standing DNET may develop secondary, histologically different neoplasm in DNET itself.
Case Report
A 14-year-old male presented with complain of headache, Immunohistochemistry showed positivity for glial fibrillary acidic protein (GFAP) in the astrocytes but not in the OLCs and ganglion cells. OLCs are strongly immunoreactive with antibodies against S-100-Protein [ Figure 4 ]. Pathological diagnosis of DNET with PA was made.
The patient recovered uneventfully. Clinical result of the surgery was excellent. No seizures or tumour recurrence have been observed during five years follow-up.
Discussion
In 1988 Dumas-Duport described the dysembryoplastic neuroepithelial tumour as a rare distinct benign cortical tumour of neuroepithelial origin. They considered the DNET to be at least partially neoplastic and formed during embryonic development from secondary germinal layer. [1, 3, 13] Malignant transformation and regrowth following subtotal resection supports the hypothesis of neoplastic origin. [5, 7, 8, 10] Till date only two cases of PA arising in association with DNETs are reported. [1, 2] DNETs are most commonly seen in temporal lobe of cerebral cortex. [1] [2] [3] [4] 14] Occasionally DNET has been found in caudate nucleus, septum pellucidum, brainstem and cerebellum. [2, 4] Occasional multifocal DNETs are associated with neurofibromatosis, XXY syndrome and intradural spinal lipoma. [11] DNET usually occur in 6-20 years of age range. Males are affected more frequently than females. [4] Review of literature suggest that development of pilocytic astrocytoma, recurrence and malignant transformation occurs mainly in childhood and young age with predilection to temporal and frontal cortex. [1, 2, 5, [7] [8] [9] [10] Intracranial hypertension and neurologic deficits are not common with DNETs. [4, 14] The signs of raised intracranial pressure suggest malignant transformation. [1] On computed tomography DNETs are typically well-demarcated, hypodense cortical lesions. MR images often show a solid and cystic mass. The solid components often appear multinodular, hypointense on T1-weighted MR images, hyperintense on T2-weighted MR images, and occasionally weakly enhancing. [1, 2, 11, 13] In our case, the clinical and radiological features were not entirely specific to DNET; dilemma occurs between DNET and low grade astrocytoma.
Histologically DNET divided into a simple, complex and non-specific form. The simple form consists of only glioneuronal elements without multinodular architecture. The complex form consists of glioneuronal elements, multinodular architecture, and associated cortical dysplasia. The nonspecific form has neither glioneuronal elements nor the multinodular architecture. It resembles a low-grade astrocytoma but has clinical and radiological features more consistent with a DNET. [4, [13] [14] [15] Occasional DNET may show presence of increased cellularity, pleomorphism, cytological atypia, microvascular proliferation, calcification, necrosis, high MIB-1 labeling indices and extensive involvement of surrounding structures. [1, 3, 4, 10, 11, 13, 15] Theoretically, overgrowth of any components of DNET may result in an independent tumour. [1] However, commonly associated secondary neoplasm with DNETs are PA, anaplastic astrocytoma and glioblastoma suggesting that astrocytic component has more proliferative potential than other component of DNET. [1, 2, 7, 8, 13] DNET with unresected, incompletely resected or even completely removed tumour can show development of pilocytic astrocytoma, recurrence or malignant transformation over a period of 3-11 years. [1, 2, [5] [6] [7] [8] [9] The combined mutagenic effects of radiotherapy and chemotherapy may cause or accelerate the malignant transformation. [8] In all cases of DNET with PA, recurrence and malignant transformation common factor is subtotal excision of tumor and it is probably the major risk factor for the unstable behaviour of DNET in such cases. These might serve as a warning for considering this entity as totally benign. [1, 2, [5] [6] [7] [8] [9] In our case we think that unresected long standing DNET made suitable condition for overgrowth of astrocytic component within the DNET itself.
DNET must be differentiated from low grade gliomas especially oligodendrogliomas, mixed oligo-astrocytomas or astrocytomas in order to avoid unnecessary post surgical radiotherapy or chemotherapy. [3, 4] Natural history of DNET is not yet completely defined. [2, 13] DNET appear to be remarkably stable in terms of biologic behavior. [13] Complete surgical resection without any adjuvant radiotherapy or chemotherapy is recommended treatment as it gives excellent control of seizures. [2, 4, 8, [11] [12] [13] However, long term follow-up is required because majority of recurrence and malignant transformation occurs after 3 years. [1, 2, [5] [6] [7] [8] [9] Our patient had neither undergone previous surgery nor received any adjuvant therapy and hence this case is a de novo development of PA in a DNET.
Conclusion
DNET is a rare mixed neuroepithelial tumour of younger patients who present with refractory seizures. The early recognition of DNET is important as it has an excellent prognosis on complete surgical excision without use of adjunct therapies. Unresected or incompletely removed DNET and secondary radio-chemotherapy may give rise to recurrence and malignancy. Most common secondary neoplasm is astrocytic in origin. The development of the secondary neoplasm challenges the stability in terms of biological behaviour and highlights the importance of complete surgical excision and close follow up.
